\-\ Texto\\:\\ \ \(0\)\
\-\ abdominal\\ mass\\ noted\\ on\\ well\\-child\\ exam\\.\ \(0\)\
\-\ monitor\\ \\‚\\Ä\\ì\\ early\\ detection\\ vital\\!\ \(0\)\
\-\ baseline\\ ct\\ at\\ diagnosis\ \(0\)\
\-\ us\\/mr\\ alternating\\ every\\ 3\\-4\\ months\\ until\\ age\\ 7\ \(0\)\
\-\ \\(based\\ on\\ national\\ wilms\\‚\\Ä\\ô\\ tumor\\ studies\\ \\‚\\Ä\\ì\\ 6\\ month\\ time\\ frame\\ for\\ met\\ development\\)\ \(0\)\
\-\ r\\/o\\ associated\\ syndromes\\ \\(beckwidth\\-wiedemann\\,\\ wagr\\ etc\\.\\)\ \(0\)\
\-\ most\\ will\\ spontaneously\\ resolve\\ but\\ enlargement\\ suggests\\ degeneration\\ to\\ wilms\\ tumor\ \(0\)\
\-\ us\\:\\ diffusely\\ enlarged\\,\\ lobulated\\ contour\\ and\\ hypoechoic\\ cortical\\ masses\ \(0\)\
\-\ ct\\:\\ diffuse\\ enlargement\\,\\ multiple\\ round\\ masses\\ of\\ low\\ attenuation\\,\\ symmetry\\,\\ compressed\\ central\\ enhancing\\ kidney\\ parenchyma\ \(0\)\
\-\ nephroblastomatosis\ \(5\)\
\-\ wilms\\ tumor\ \(0\)\
\-\ nephroblastomatosis\ \(5\)\
\-\ 16\\ month\\-old\\ asymptomatic\\ female\\ reaching\\ normal\\ developmental\\ milestones\\ without\\ significant\\ pmh\\.\ \(0\)\
\-\ multiple\\ foci\\ of\\ \\‚\\Ä\\únephrogenic\\ rests\\‚\\Ä\\ù\\ \\(embryonic\\ tissue\\ persistence\\)\ \(0\)\
\-\ risk\\ for\\ malignant\\ transformation\\ \\(wilms\\ tumor\\)\ \(0\)\
\-\ genetic\\ link\\ \\ \ \(0\)\
\-\ types\\:\ \(11\)\
\-\ 1\\.\\ intralobar\\ \\‚\\Ä\\ì\\ random\\,\\ less\\ common\\ than\\ perilobar\\,\\ higher\\ risk\\ or\\ malignant\\ transformation\\,\\ associated\\ with\\ wagr\\,\\ drash\\ syndrome\\,\\ sporadic\\ aniridia\\ \\(30\\%\\ progress\\ to\\ wilms\\)\\ \ \(0\)\
\-\ 2\\.\\ perilobar\\ \\‚\\Ä\\ì\\ multiple\\ at\\ cortio\\-medullary\\ jxn\\ or\\ cortex\\,\\ associated\\ with\\ beckwith\\-wiedemann\\ \\(5\\%\\ progress\\ to\\ wilms\\)\\,\\ hemihypertrophy\\,\\ \\ perlman\\ syndrome\\,\\ trisomy\\ 18\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ wilms\\:\\ 0\\.4711379452664288\ \(0\)\
\-\ wagr\\:\\ 0\\.22884698172225035\ \(0\)\
\-\ perilobar\\:\\ 0\\.2186755082915147\ \(0\)\
\-\ nephroblastomatosis\\:\\ 0\\.191115786181255\ \(0\)\
\-\ tumor\\:\\ 0\\.14969850443765\ \(0\)\
\-\ transformation\\:\\ 0\\.14616781539147136\ \(0\)\
\-\ progress\\:\\ 0\\.14570750999722604\ \(0\)\
\-\ drash\\:\\ 0\\.11442349086112517\ \(0\)\
\-\ jxn\\:\\ 0\\.11442349086112517\ \(0\)\
\-\ perlman\\:\\ 0\\.11442349086112517\ \(0\)\
\-\ us\\:\\ 0\\.1138287620098798\ \(0\)\
\-\ associated\\:\\ 0\\.1131361169423419\ \(0\)\
\-\ enlargement\\:\\ 0\\.1097070655004179\ \(0\)\
\-\ aniridia\\:\\ 0\\.1057293665213632\ \(0\)\
\-\ hemihypertrophy\\:\\ 0\\.1057293665213632\ \(0\)\
\-\ multiple\\:\\ 0\\.10498949518744587\ \(0\)\
\-\ risk\\:\\ 0\\.10224712899261013\ \(0\)\
\-\ malignant\\:\\ 0\\.10200630211770728\ \(0\)\
\-\ masses\\:\\ 0\\.0974192827354698\ \(0\)\
\-\ nephrogenic\\:\\ 0\\.0955578930906275\ \(0\)\
\-\ frame\\:\\ 0\\.09423635929618777\ \(0\)\
\-\ symmetry\\:\\ 0\\.09423635929618777\ \(0\)\
\-\ embryonic\\:\\ 0\\.09304088656355043\ \(0\)\
\-\ milestones\\:\\ 0\\.09194950546623336\ \(0\)\
\-\ rests\\:\\ 0\\.09094553217957471\ \(0\)\
\-\ intralobar\\:\\ 0\\.09094553217957471\ \(0\)\
\-\ random\\:\\ 0\\.09094553217957471\ \(0\)\
\-\ trisomy\\:\\ 0\\.0883411178418392\ \(0\)\
\-\ national\\:\\ 0\\.0875807050248999\ \(0\)\
\-\ month\\:\\ 0\\.08704897650576686\ \(0\)\
\-\ alternating\\:\\ 0\\.0868637687508655\ \(0\)\
\-\ reaching\\:\\ 0\\.0868637687508655\ \(0\)\
\-\ syndrome\\:\\ 0\\.08626903989962013\ \(0\)\
\-\ met\\:\\ 0\\.0855422349564258\ \(0\)\
\-\ persistence\\:\\ 0\\.08325538112647136\ \(0\)\
\-\ sporadic\\:\\ 0\\.08132187376315156\ \(0\)\
\-\ compressed\\:\\ 0\\.07749148087295067\ \(0\)\
\-\ link\\:\\ 0\\.07716567112444486\ \(0\)\
\-\ baseline\\:\\ 0\\.07565263788402644\ \(0\)\
\-\ resolve\\:\\ 0\\.07565263788402644\ \(0\)\
\-\ detection\\:\\ 0\\.07456125678670937\ \(0\)\
\-\ syndromes\\:\\ 0\\.07355728350005072\ \(0\)\
\-\ monitor\\:\\ 0\\.07308390769573568\ \(0\)\
\-\ spontaneously\\:\\ 0\\.07285375499861302\ \(0\)\
\-\ etc\\:\\ 0\\.07037828152296115\ \(0\)\
\-\ every\\:\\ 0\\.06930251084467189\ \(0\)\
\-\ degeneration\\:\\ 0\\.06653803942136306\ \(0\)\
\-\ diffusely\\:\\ 0\\.06653803942136306\ \(0\)\
\-\ suggests\\:\\ 0\\.06599847364777525\ \(0\)\
\-\ lobulated\\:\\ 0\\.06599847364777525\ \(0\)\
\-\ higher\\:\\ 0\\.06498434821967218\ \(0\)\
\-\ pmh\\:\\ 0\\.06474312982260828\ \(0\)\
\-\ contour\\:\\ 0\\.06438978335597369\ \(0\)\
\-\ vital\\:\\ 0\\.06371161981782084\ \(0\)\
\-\ developmental\\:\\ 0\\.06187277682889661\ \(0\)\
\-\ hypoechoic\\:\\ 0\\.061134742198214145\ \(0\)\
\-\ until\\:\\ 0\\.05953850150551886\ \(0\)\
\-\ development\\:\\ 0\\.05915014323647246\ \(0\)\
\-\ round\\:\\ 0\\.058625883102452994\ \(0\)\
\-\ foci\\:\\ 0\\.058480032969909175\ \(0\)\
\-\ cortex\\:\\ 0\\.05826438920450246\ \(0\)\
\-\ parenchyma\\:\\ 0\\.05812265922114979\ \(0\)\
\-\ 16\\:\\ 0\\.05575386315810163\ \(0\)\
\-\ attenuation\\:\\ 0\\.05474540302822938\ \(0\)\
\-\ ct\\:\\ 0\\.05447925851900345\ \(0\)\
\-\ 18\\:\\ 0\\.054218309925238004\ \(0\)\
\-\ at\\:\\ 0\\.054050428587030075\ \(0\)\
\-\ to\\:\\ 0\\.05366182717050912\ \(0\)\
\-\ studies\\:\\ 0\\.05248549436453392\ \(0\)\
\-\ based\\:\\ 0\\.051828644289572054\ \(0\)\
\-\ early\\:\\ 0\\.05157524233635854\ \(0\)\
\-\ cortical\\:\\ 0\\.05136791579670905\ \(0\)\
\-\ kidney\\:\\ 0\\.05026625778765783\ \(0\)\
\-\ or\\:\\ 0\\.049781708877454825\ \(0\)\
\-\ 30\\:\\ 0\\.04880985204780116\ \(0\)\
\-\ enlarged\\:\\ 0\\.04877635945094512\ \(0\)\
\-\ asymptomatic\\:\\ 0\\.0487096413677349\ \(0\)\
\-\ less\\:\\ 0\\.04867641493752403\ \(0\)\
\-\ central\\:\\ 0\\.04778010729107374\ \(0\)\
\-\ will\\:\\ 0\\.04605127868846739\ \(0\)\
\-\ age\\:\\ 0\\.04491958806507066\ \(0\)\
\-\ diffuse\\:\\ 0\\.04487049614302926\ \(0\)\
\-\ enhancing\\:\\ 0\\.04482159561298257\ \(0\)\
\-\ for\\:\\ 0\\.04337230872644536\ \(0\)\
\-\ on\\:\\ 0\\.043218453965490906\ \(0\)\
\-\ time\\:\\ 0\\.042409290802700145\ \(0\)\
\-\ months\\:\\ 0\\.04164769373706337\ \(0\)\
\-\ significant\\:\\ 0\\.041311200440676515\ \(0\)\
\-\ low\\:\\ 0\\.04105558521743934\ \(0\)\
\-\ common\\:\\ 0\\.04057685546146053\ \(0\)\
\-\ than\\:\\ 0\\.04055947088477617\ \(0\)\
\-\ abdominal\\:\\ 0\\.03913240979051085\ \(0\)\
\-\ noted\\:\\ 0\\.03793552765621239\ \(0\)\
\-\ without\\:\\ 0\\.03773975826293463\ \(0\)\
\-\ tissue\\:\\ 0\\.037533341590179736\ \(0\)\
\-\ most\\:\\ 0\\.03723661233112585\ \(0\)\
\-\ diagnosis\\:\\ 0\\.03709083924740228\ \(0\)\
\-\ exam\\:\\ 0\\.03601813718565918\ \(0\)\
\-\ but\\:\\ 0\\.03538142118551565\ \(0\)\
\-\ female\\:\\ 0\\.034526013485623924\ \(0\)\
\-\ normal\\:\\ 0\\.029213248489657197\ \(0\)\
\-\ with\\:\\ 0\\.028020637849148735\ \(0\)\
\-\ of\\:\\ 0\\.028003905522272138\ \(0\)\
\-\ mass\\:\\ 0\\.02733006202376695\ \(0\)\
\-\ and\\:\\ 0\\.014784862308250744\ \(0\)\
